About this episode
The markets are reacting to comments from Fed Chair Jerome Powell, who announced a plan to taper its asset purchases faster. He--and the rest of the economist community--is ready to retire the word “transitory,” but his comments have not retired questions and concerns from investors. CNBC’s Steve Liesman explains Powell’s comments. CEO of Lazard’s Financial Advisory business Peter Orszag discusses Fed leadership and Lazard’s efforts to quantify climate issues in the equities market. The FDA has narrowly endorsed Merck’s oral Covid treatment pill; former FDA Commissioner Dr. Scott Gottlieb discusses therapeutics, vaccine efficacy against the omicron variant, and Covid-19’s evolution. Plus, how much do you love Tesla? Enough for a tattoo?
In this episode:
Dr. Scott Gottlieb, @ScottGottliebMD
Peter Orszag, @porszag
Steve Liesman, @SteveLiesman
Joe Kernen, @JoeSquawk
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Squawk Pod
25 Years Later 9/11/26
Squawk Pod
AI Alarms, Canada’s Opposition, The GOP Convention 9/10/26
Squawk Pod
Microsoft’s Brad Smith & Utah Gov. Cox: AI, Teaching, & Peace 9/9/26
Squawk Pod
GLPs & Fraud with Dr. Oz & Kevin O’Leary’s $11m Baseball Card 9/8/26
Squawk Pod